New Cure for Deadly Visceral Leishmaniasis (Kala-Azar) Approved by Government of India

Media contact

Phone:
206-709-3400
Mail:
[email protected]

US/International
Rabia Shirazi, The Halo Project
Phone: 201.683.9055
Email: [email protected]

India:
Nymphia Vishin/Imprimis Life
Phone: +91.98.99.216.600
Email: [email protected]

SAN FRANCISCO / NEW DELHI, India -- The Institute for OneWorld Health, a nonprofit pharmaceutical company that develops medicines for neglected diseases of the developing world, today announced that the Drug-Controller General of India (DCGI) has approved Paromomycin Intramuscular (IM) Injection for the treatment of Visceral Leishmaniasis (VL), the second most deadly parasitic disease in the world following malaria.

To view the full press release, visit The Institute for OneWorld Health Web site.

Sign up for The Optimist newsletter

Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.